Bal Pharma Ltd vs Bharat Immunological Biological Corporation Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Bal Pharma Ltd is ₹ 86.7 as of 12 Jun 15:30 . The P/E Ratio of Bal Pharma Ltd changed from 16.8 on March 2021 to 18.4 on March 2025 . This represents a CAGR of 1.84% over 5 yearsThe P/E Ratio of Bharat Immunological & Biological Corporation Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Bal Pharma Ltd changed from ₹ 79.67 crore on March 2021 to ₹ 132.4 crore on March 2025 . This represents a CAGR of 10.69% over 5 yearsThe Market Cap of Bharat Immunological & Biological Corporation Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Bal Pharma Ltd for the Mar '26 is ₹ 83.84 crore as compare to the Dec '25 revenue of ₹ 88.02 crore. This represent the decline of -4.75% The revenue of Bharat Immunological & Biological Corporation Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Bal Pharma Ltd for the Mar '26 is ₹ 10.33 crore as compare to the Dec '25 ebitda of ₹ 9.87 crore. This represent the growth of 4.66% The ebitda of Bharat Immunological & Biological Corporation Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Bal Pharma Ltd changed from ₹ 0.26 crore to ₹ 3.6 crore over 8 quarters. This represents a CAGR of 272.10% The net profit of Bharat Immunological & Biological Corporation Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Bal Pharma Ltd changed from 16.29 % on March 2021 to 24.49 % on March 2025 . This represents a CAGR of 8.50% over 5 yearsThe Dividend Payout of Bharat Immunological & Biological Corporation Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Bal Pharma Ltd

Bal Pharma Limited (BPL), a member of the Mcro Laboratories Group, was incorporated as a private limited company in May 1987.
In March 1990, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations. BPL manufactures and markets pharmaceutical formulations -- paracetamol, aluminium hydroxide, povidone iodine, alprazolam, gliclazide, griseofulvin, lactobacillus, rifampicin, piroxicam amoxycillin, etc.
The company promotes its products through the common sales force of the group but proposes to induct its own soon.
It came out with a public issue in Feb.'95 for manufacture of bulk drugs and expansion of pharmaceutical formulations.

About Bharat Immunological & Biological Corporation Ltd

The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology.
BIBCOL was incorporated in 1989.
The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets. The company's manufacturing unit is located in Bulandshahr Dist., Uttar Pradesh.
BIBCL installed a plant of 100 mln units.
Commercial production of the OPV started from Jan'96. The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme.

FAQs for the comparison of Bal Pharma Ltd and Bharat Immunological & Biological Corporation Ltd

Which company has a larger market capitalization, Bal Pharma Ltd or Bharat Immunological & Biological Corporation Ltd?

Market cap of Bal Pharma Ltd is 138 Cr while Market cap of Bharat Immunological & Biological Corporation Ltd is 73 Cr

What are the key factors driving the stock performance of Bal Pharma Ltd and Bharat Immunological & Biological Corporation Ltd?

The stock performance of Bal Pharma Ltd and Bharat Immunological & Biological Corporation Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bal Pharma Ltd and Bharat Immunological & Biological Corporation Ltd?

As of June 14, 2026, the Bal Pharma Ltd stock price is INR ₹86.7. On the other hand, Bharat Immunological & Biological Corporation Ltd stock price is INR ₹17.02.

How do dividend payouts of Bal Pharma Ltd and Bharat Immunological & Biological Corporation Ltd compare?

To compare the dividend payouts of Bal Pharma Ltd and Bharat Immunological & Biological Corporation Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.